Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/2007
06/28/2007US20070148136 Methods of using ammonia oxidizing bacteria
06/28/2007US20070148135 Combination bacteriolytic therapy for the treatment of tumors
06/28/2007US20070148074 Nanoparticle based stabilization of ir fluorescent dyes
06/27/2007EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
06/27/2007EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
06/27/2007EP1800664A1 Pharmaceutical formulations for parenteral administration comprising epothilone
06/26/2007US7235691 Dissolving modafinil in a solvent selected from acetone, acetonitrile, benzyl alcohol, dimethyl formamide, methyl ethyl ketone, pyrrolidone and mixtures thereof, crystallizing, and separating the solvent; high purity; X-ray diffraction patterns; dosage forms
06/26/2007US7235628 Analogues of GLP-1
06/26/2007US7235564 11'-substituted; potent inhibitors of cellular mitosis and proliferation
06/26/2007US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
06/26/2007US7235248 Pharmaceutical compositions comprising cyclosporins
06/21/2007WO2005037223A3 Methods and compositions for immunomodulation
06/21/2007WO2004084833A8 Jucara and açai fruit-based dietary supplements
06/21/2007WO2004078135A3 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF
06/21/2007US20070142399 Dual function drugs and uses thereof
06/21/2007US20070142348 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070141632 Function and regulation of angiopoietin-3/angiopoietin-4
06/21/2007US20070141140 Semi-solid formulations for immediate release intended for the oral administration of drugs
06/21/2007US20070141136 intravenously administering to mammal a therapeutically effective amount of a liposomal suspension of small unilamellar vesicles (SUVs), wherein SUVs predominantly comprise phospholipids selected from phosphatidycholine, phosphatidylglycerol and phosphatidylserine
06/21/2007US20070141080 Treating severe acute respiratory syndrome
06/21/2007US20070141068 Methods for the treatment of carcinoma
06/21/2007US20070140988 Therapeutic agent for periodontal disease
06/20/2007EP1796699A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children.
06/20/2007EP1758540A4 Purification of insulin-like material by reverse phase chromatography
06/20/2007EP1663186B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins
06/20/2007CN1984926A Fsh糖基化突变体 Fsh glycosylation mutants
06/20/2007CN1984921A Modulation of survivin expression
06/20/2007CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor
06/20/2007CN1982355A Anti-microbial and oxidative co-polymer
06/20/2007CN1982308A Substituted pyrazoles
06/20/2007CN1981747A Rapidly disintegrating methylcellulose tablets
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232841 N-{4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexyl}-2-[2-({4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexylcarbamoyl}-methyl)-phenyl]-acetamide; treating COPD
06/19/2007US7232824 Used for treating disorders with enhanced activity of transforming growth factor beta TGF- beta, kidney disorders associated with unregulated TGF- beta activity and excessive fibrosis including glomerulonephritis (GN), mesangial proliferative GN, immune GN, and crescentic GN
06/19/2007US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
06/19/2007US7232805 Cobalamin conjugates for anti-tumor therapy
06/19/2007US7232562 E38N interferon gamma polypeptide variants
06/14/2007WO2007065967A1 A vaccine suitable for use against the next influenza a pandemia
06/14/2007WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases
06/14/2007WO2005044189A3 Dialysates and methods and systems related thereto
06/14/2007WO2005016236A3 Antibodies that immunospecifically bind to trail receptors
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/14/2007US20070135478 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis
06/14/2007US20070135470 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof
06/14/2007US20070135400 Estradiol derivatives
06/14/2007US20070135382 Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions
06/14/2007US20070135364 Compositions and methods for the modulation of the expression of b7 protein
06/14/2007US20070135353 Crystalline n-formyl hydroxylamine compounds
06/14/2007US20070134757 Method for cleaving proteins
06/14/2007US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds
06/14/2007US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
06/14/2007US20070134269 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
06/14/2007US20070134268 Vaccines
06/14/2007US20070134214 Inactivated host cell delivery of polynucleotides encoding immunogens
06/13/2007EP1558931B1 Analysis of pharmaceutical solubility and stability
06/13/2007EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/13/2007EP1381352B1 Transdermal patch for administering fentanyl
06/13/2007EP1105145B1 Reducing serum homocysteine concentration by the use of allium and vitamins
06/13/2007CN1980916A Chemokine receptor binding heterocyclic compounds
06/13/2007CN1980692A Polypeptides for inducing a protective immune response against staphylococcus aureus
06/12/2007US7230133 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis
06/12/2007US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer
06/12/2007US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain
06/12/2007US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
06/12/2007US7230003 Aromatic prodrugs of propofol, compositions and uses thereof
06/12/2007US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists
06/12/2007US7229648 Homeopathic formulations useful for treating pain and/or inflammation
06/12/2007US7229413 Echogenic coatings with overcoat
06/12/2007CA2238410C Novel indole-2,3-dione-3-oxime derivatives
06/07/2007WO2007063186A1 Face mask
06/07/2007WO2007011232A3 Lipid lowering agents for increasing bmd
06/07/2007WO2005052132A3 Mbms as modifiers of branching morphogenesis and methods of use
06/07/2007WO2005046596A3 Stem cell culture medium and method of using said medium and the cells
06/07/2007WO2005020918A3 Ultrasonic concentration of drug delivery capsules
06/07/2007WO2005016234A3 Compositions, methods, apparatuses, and systems for singlet oxygen delivery
06/07/2007WO2005011619A3 Lung-expressed polypeptides
06/07/2007WO2004112702A3 Low dose pharmaceutical powders for inhalation
06/07/2007WO2004110369A3 Cell surface protein associated with human chronic lymphocytic leukemia
06/07/2007US20070129740 Methods And Devices For Creating Electrical Block At Specific Targeted Sites In Cardiac Tissue
06/07/2007US20070129439 Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use
06/07/2007US20070129396 Muscarinic acetylcholine receptor antagonists
06/07/2007US20070129392 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007US20070129311 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents
06/07/2007US20070129292 Treatment of aspergillus infections with alpha thymosin peptides
06/07/2007US20070128642 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders
06/07/2007US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced
06/07/2007US20070128241 Methods, compositions, apparatuses containing tetrameric oxygen
06/07/2007US20070128216 Derived from recombinant attenuated intracellular pathogenic bacteria, specifically, attenuated Mycobacteria that over-express and secrete major extracellular proteins; useful in inducing immune responses in hosts
06/07/2007US20070128181 Administering within 12 hours after cardiac surgery to patient a blood clotting inhibitor such as a combination of dipyridamole and aspirin, wherein cardiac surgery does not include vein graft coronary artery bypass graft surgery; decreases complications without significant adverse effects; efficiency
06/07/2007US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
06/06/2007EP1792628A1 Vaccines
06/06/2007EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases
06/06/2007EP1684768A4 Methods of treating eczema
06/06/2007EP1682606B1 Anion-binding polymers and uses thereof
06/06/2007EP1620459A4 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 295